Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Truist Securities Downgrades Aerie Pharmaceuticals to Hold

Truist Securities Downgrades Aerie Pharmaceuticals to Hold

Truist Securities analyst Gregory Fraser downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Hold.

August 24, 2022

1 minute read

Truist Securities analyst Gregory Fraser downgrades Aerie Pharmaceuticals (NASDAQ:AERI) from Buy to Hold.

Analyst Ratings for Cloudflare

September 8, 10:54 AM

Within the last quarter, Cloudflare (NYSE:NET) has observed the following analyst ratings:

July 21, 5:05 AM

The global cryptocurrency market valuation moved lower on Thursday, but it still managed to remain above the $1 trillion mark.

June 14, 1:43 PM

Oppenheimer analyst Jason Helfstein reiterated an Outperform rating on Integral Ad Science Holding Corp. (NASDAQ: IAS), raising the

April 17, 4:14 PM

Revolutionizing Psychedelics: 2 Industry Leaders Team Up On Clinical-Grade MDMA Capsules